{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:46:37Z","timestamp":1768319197714,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/igc.0b013e3181d373a5","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T14:09:18Z","timestamp":1291385358000},"page":"404-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy of Human Papillomavirus 16\/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years"],"prefix":"10.1016","volume":"20","author":[{"given":"Ryo","family":"Konno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Dobbelaere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e3181d373a5_bb0005","unstructured":"Vital Statistics of Japan (Ministry of Health, Labour & Walfare). Available at: http:\/\/ganjoho.ncc.go.jp\/professional\/statistics\/statistics.html. Accessed August 13, 2009."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0010","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/jjco\/hym112","article-title":"Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries","volume":"37","author":"Marugame","year":"2007","journal-title":"Jpn J Clin Oncol."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/aje\/kwn036","article-title":"Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis","volume":"168","author":"Koshiol","year":"2008","journal-title":"Am J Epidemiol."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0020","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/ijc.22195","article-title":"Do we need a different strategy for HPV screening and vaccination in East Asia?","volume":"119","author":"Miura","year":"2006","journal-title":"Int J Cancer."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen?","volume":"111","author":"Munoz","year":"2004","journal-title":"The international perspective. Int J Cancer."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0030","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1349-7006.2009.01161.x","article-title":"Human papillomavirus infections among Japanese women: age-related prevalence and type-specif ic risk for cervical cancer","volume":"100","author":"Onuki","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/427557","article-title":"Development and duration of human papillomavirus lesions, after initial infection","volume":"191","author":"Winer","year":"2005","journal-title":"J Infect Dis."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1586\/14760584.7.10.1465","article-title":"AS04-adjuvanted human papillomavirus-16\/18 vaccination: recent advances in cervical cancer prevention","volume":"7","author":"Schwarz","year":"2008","journal-title":"Expert Rev Vaccines."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0045","first-page":"111","article-title":"A retrospective study of young cervical cancer at the Hyogo medical center for adults from 1976 to 2005 [in Japanese]","volume":"59","author":"Takekida","year":"2007","journal-title":"Sanpu No Shinpo."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactor: implications for screening and prevention","volume":"98","author":"Castellsague","year":"2006","journal-title":"J Natl Cancer Inst."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24 year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0060","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0065","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0070","series-title":"25th International Papillomavirus Conference and Clinical Workshop","article-title":"Immunogenicity and safety of the HPV-16\/18 AS04-adjuvanted vaccine up to 7.3 years","author":"Carvalho","year":"2009"},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0075","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ygyno.2009.01.011","article-title":"Long-term persistence of anti\u2013HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses","volume":"115","author":"David","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)\u201316\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0085","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/IGC.0b013e3181a23c0e","article-title":"Immunogenicity, reactogenicity and safety of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine in Japanese women: interim analysis of a phase II double-blind, randomized controlled trial at month 7","volume":"19","author":"Konno","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.vaccine.2004.07.046","article-title":"Efficacy and other milestones for human papillomavirus vaccine introduction","volume":"23","author":"Pagliusi","year":"2004","journal-title":"Vaccine."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0095","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1042\/BST0351456","article-title":"HPV: from infection to cancer","volume":"35","author":"Stanly","year":"2007","journal-title":"Biochem Soc Trans."},{"key":"10.1111\/IGC.0b013e3181d373a5_bb0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4161\/hv.5.5.7211","article-title":"Safety of human papillomavirus (HPV)\u201316\/18 AS04 adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials","volume":"5","author":"Descamps","year":"2009","journal-title":"Hum Vaccin."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181d373a5","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24191323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24191323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:08:05Z","timestamp":1753232885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24191323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1048891X24191323"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181d373a5","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Human Papillomavirus 16\/18 AS04-Adjuvanted Vaccine in Japanese Women Aged 20 to 25 Years","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181d373a5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2010 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}